Release Date: 13/03/19 08:57 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 579.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%